临床试验中复合终点的时间到事件分析的统计考虑和挑战
Kaiyi Chen1, Yu Du1, Yuxin Zhu2,3,4
1Global Statistical Science, Eli Lilly and Company, Indianapolis, Indiana, USA.
Therapeutic innovation & regulatory science
|July 22, 2025
概括
临床试验中的复合终点可以膨胀统计能力,但可能会掩盖个别结果效应. 本研究探讨了矛盾的结果和考克斯模型.
科学领域:
- 临床试验方法论 临床试验方法论
- 医学中的统计分析.
- 心血管和脏研究成果研究结果
背景情况:
- 复合终点在临床研究中经常被用于增加统计能力和事件率.
- 这种策略在心血管和结局研究中很常见,因为单个事件的发生率很低.
- 监管指南强调评估复合终点的每个组成部分的临床相关性.
研究的目的:
- 调查解释复合终点与单个组件的危险比率中的争议.
- 分析关于治疗效果的CLEAR结局试验中的一个矛盾观察.
- 重新评估Cox比例危险模型对复合终点的适用性.
主要方法:
- 对复合终点的危险比率解释的理论研究.
- 模拟研究以评估考克斯比例危险模型的性能.
- 分析来自CLEAR结局试验的数据.
主要成果:
- 确定了一个矛盾的情景,其中复合终点显示治疗效果不如单个组件那么有利.
- 该研究强调了在使用复合终点时对治疗效果的潜在误解.
- 重新评估质疑Cox模型在某些复合终点场景中的普遍适用性.
结论:
- 复合终点需要仔细解释,因为它们可以掩盖单个组件的差异效应.
- 对于呈现异质性的复合终点,考克斯比例危险模型的标准应用可能需要重新评估.
- 需要进一步的方法研究,以确保复合终点的准确和临床意义分析.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
291
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
291
Assumptions of Survival Analysis
199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Introduction To Survival Analysis
402
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
402
Kaplan-Meier Approach
272
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
272
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
177
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
177
Actuarial Approach
137
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
137


